176 related articles for article (PubMed ID: 14995928)
1. Dynamics of selected MHC class I and II molecule expression in the course of HPV positive CIN treatment with the use of human recombinant IFN-gamma.
Sikorski M; Bobek M; Zrubek H; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2004 Mar; 83(3):299-307. PubMed ID: 14995928
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix.
Chil A; Sikorski M; Bobek M; Jakiel G; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1146-52. PubMed ID: 14616262
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of cervical langerhans cell counts in the course of HPV-positive CIN treatment with the use of human recombinant interferon gamma.
Sikorski M; Bieda T; Bobek M; Zrubek H
Eur J Gynaecol Oncol; 2005; 26(3):294-8. PubMed ID: 15991530
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human interferon gamma in the treatment of cervical intraepithelial neoplasia (CIN) associated with human papillomavirus (HPV) infection.
Sikorski M; Zrubek H
Eur J Gynaecol Oncol; 2003; 24(2):147-50. PubMed ID: 12701965
[TBL] [Abstract][Full Text] [Related]
5. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.
Glew SS; Connor ME; Snijders PJ; Stanbridge CM; Buckley CH; Walboomers JM; Meijer CJ; Stern PL
Eur J Cancer; 1993; 29A(14):1963-70. PubMed ID: 8280490
[TBL] [Abstract][Full Text] [Related]
6. S100, CD68, and MHC class II molecule expression in cervical high- and low-grade HPV-induced lesions.
Cassandri F; Tozetti IA; Fernandes CE; Almeida FG; Falcão GR; Scapulatempo ID; Prata TT; Padovani CT; Alves DB; Ferreira AT; Abdo MA
Rev Soc Bras Med Trop; 2012 Feb; 45(1):3-8. PubMed ID: 22370820
[TBL] [Abstract][Full Text] [Related]
7. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
[TBL] [Abstract][Full Text] [Related]
8. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
Cromme FV; Meijer CJ; Snijders PJ; Uyterlinde A; Kenemans P; Helmerhorst T; Stern PL; van den Brule AJ; Walboomers JM
Br J Cancer; 1993 Jun; 67(6):1372-80. PubMed ID: 8390286
[TBL] [Abstract][Full Text] [Related]
9. Intralesional beta-interferon treatment of cervical intraepithelial neoplasia associated with human papillomavirus infection.
Penna C; Fallani MG; Gordigiani R; Sonni L; Taddei GL; Marchionni M
Tumori; 1994 Apr; 80(2):146-50. PubMed ID: 8016908
[TBL] [Abstract][Full Text] [Related]
10. Effects of retinoic acid combined with interferon-gamma on the expression of major-histocompatibility-complex molecules and intercellular adhesion molecule-1 in human cervical cancer.
Santin AD; Hermonat P; Ravaggi A; Chiriva-Internati M; Hiserodt JC; Tian E; Carter CA; Pecorelli S; Parham GP
Int J Cancer; 1998 Jan; 75(2):254-8. PubMed ID: 9462716
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response.
Dong DD; Yang H; Li K; Xu G; Song LH; Fan XL; Jiang XL; Yie SM
Reprod Sci; 2010 Aug; 17(8):718-23. PubMed ID: 20445010
[TBL] [Abstract][Full Text] [Related]
12. Efficacy trial of topically administered interferon gamma-1 beta gel in comparison to laser treatment in cervical intraepithelial neoplasia.
Schneider A; Grubert T; Kirchmayr R; Wagner D; Papendick U; Schlunck G
Arch Gynecol Obstet; 1995; 256(2):75-83. PubMed ID: 7611822
[TBL] [Abstract][Full Text] [Related]
13. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Efficacy of Trichloroacetic Acid in the Treatment of Cervical Intraepithelial Neoplasia.
Geisler S; Speiser S; Speiser L; Heinze G; Rosenthal A; Speiser P
Obstet Gynecol; 2016 Feb; 127(2):353-9. PubMed ID: 26942365
[TBL] [Abstract][Full Text] [Related]
15. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia.
Kawase K; Taguchi A; Ishizaka A; Lin J; Ueno T; Yoshimoto D; Eguchi S; Mori S; Sone K; Mori M; Yonekura S; Hanazawa T; Maeda D; Kukimoto I; Mano H; Osuga Y; Kawana K; Kawazu M
HLA; 2024 Jun; 103(6):e15509. PubMed ID: 38837741
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Benedetto A; Paba P; Costa S; Bonifacio D; Di Bonito P; Accardi L; Favalli C; Syrjänen K;
J Clin Pathol; 2006 Jan; 59(1):40-7. PubMed ID: 16394279
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients treated with recombinant human interferon gamma for cervical intraepithelial neoplasia.
Sikorski M; Zrubek H
Int J Gynaecol Obstet; 2003 Aug; 82(2):179-85. PubMed ID: 12873779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
